ADMA
ADMA
NASDAQ · Biotechnology

Adma Biologics Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$8.70
+0.01 (+0.12%)
As of Jun 24, 9:57 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 8 80%
Hold 2 20%
Sell 0 0%
Price Target
Analyst Price Target +304.8% upside
Low Target $21.76
Average Target $35.22
High Target $46.82
Current Price $8.70
Current
$8.70
Target
$35.22
$21.76 $35.22 avg $46.82
Scenario Analysis
Bear Case
$21.76
150.1%
Low target
Base Case
$35.22
+304.8%
Avg target
Bull Case
$46.82
+438.2%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$20.46
-57.5% from high
52-Week Low
$7.21
+20.7% from low
50-Day SMA
$17.86
-51.3% vs SMA
200-Day SMA
$17.61
-50.6% vs SMA
RSI (14)
42.2
Neutral
Target vs 52W High
$35.22
+72.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.0%